Research scientist with the New York State Department of Health (NYSDOH) were out in the field on Monday, sweeping for ticks ...
SmartRent today announced the launch of its strategic value-added reseller program to serve small and mid-market multifamily owners and operators.
Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, along with scientists from the Broad Institute of MIT and Harvard, will present ...
IITM Pravartak's Advanced Certificate Programme in Agentic AI and RAG Engineering aims to equip professionals with skills to build production-ready AI systems.
Researchers have long considered the Stuxnet attacks on Iran's nuclear centrifuges in Natanz to be the opening chapter of ...
Defender’s advantage for territory denial: drones alter the ratio of force required to overcome an entrenched defender.
AT-108 induces powerful, personalized anti-cancer responses by forcing tumor cells to present their antigens to the immune ...
In vitro data demonstratedself-complementary AAV9 (scAAV9) enabled ~30-fold higher MeCP2 protein expression compared to single-stranded AAV9 ...
Armando Solar-Lezama, Distinguished Professor of Computing and Associate Director of the Computer Science and Artificial ...
US FDA approves Regeneron’s gene therapy, Otarmeni for genetic hearing loss: Tarrytown, New York Regeneron Pharmaceuticals, Inc., a leadi ...
Opinion
allAfrica.com on MSNOpinion
Accelerating Action to End Malaria - a Test of Africa's Health Security and Sovereignty
By H.E. Dr. Jean Kaseya, Director General, Africa CDCAs Africa marks World Malaria Day 2026, one fact remains inescapable: malaria continues to impose one of the heaviest and most avoidable burdens on ...
As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results